Results 41 to 50 of about 926,443 (292)

Therapeutic antibodies under development for SARS‐CoV‐2

View, 2022
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, Changhai Lei, Shi Hu   +7 more
doaj   +1 more source

Pathophysiology, histopathology and therapeutic of SARS-CoV-2 [PDF]

, 2020
The rapid transmission of SARS-CoV-2 through the world has induced the scientist to understand the histopathology of the virus and then to find an effective drug.
Al-Gheethi, Adel, Al-Shorgani, Najeeb, Hezam, Kamal, Noman, Efaq, Othman, Norzila, Radin Mohamed, Radin Maya Saphira, Talip, Balkis   +6 more
core  

Guillain‐Barré syndrome after SARS‐CoV‐2 infection

Journal of General and Family Medicine, 2022
We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita, Masamichi Sato, Yutaka Iizuka, Yamato Mashimo, Natsumi Furuta, Satoru Kakizaki   +5 more
doaj   +1 more source

Electronic Health Record-Based Surveillance for Community Transmitted COVID-19 in the Emergency Department [PDF]

, 2020
Introduction: SARS-CoV-2, a novel coronavirus, manifests as a respiratory syndrome (COVID-19) and is the cause of an ongoing pandemic. The response to COVID-19 in the United States has been hampered by an overall lack of diagnostic testing capacity.
Barclay-Buchanan, Ciara, Batt, Robert, Glazer, Joshua M., Hekman, Daniel J., Kuehnel, Nicholas, Patterson, Brian W., Pulia, Michael S., Ross, Joshua, Sharp, Brian   +8 more
core  

Erythema Multiforme Major following SARS‐CoV‐2 vaccine

Clinical Case Reports, 2021
Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2.
Alberto Maria Saibene, Andrea Alliata, Anna Teresa Cozzi, Alice Ottavi, Sofia Spagnolini, Carlotta Pipolo, Alberto Maccari, Giovanni Felisati   +7 more
doaj   +1 more source

Survival and disinfection of SARS-Cov-2 in environment and contaminated surface [PDF]

, 2020
The detection of SARS-Cov-2 in the sewage and water resources has increased the awareness among the people about the possibility survival of SARS-Cov-2 in the environment and the potential to transmit into the human through food chain or water resources.
Al-Gheethi, Adel, Al-Maqtari, Qais, Almoheer, Reyad, Hamdan, Rafidah, Noman, Efaq, Radin Mohamed, Radin Maya Saphira   +5 more
core  

Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19? [PDF]

, 2020
Human lungs single cell RNA sequencing data from healthy donors (elderly and young; GEO accession number GSE122960) were analyzed to isolate and specifically study gene expression in alveolar type II cells.
Abouhashem, Ahmed S., Azzazy, Hassan M. E., Sen, Chandan K., Singh, Kanhaiya   +3 more
core   +1 more source

SARS‐CoV‐2 infection with bilateral intralabyrinthine hemorrhage

Clinical Case Reports, 2022
A 47‐year‐old woman presented with the complaint of sudden hearing loss associated with vertigo. Serological testing was positive for IgM and negative for IgG COVID‐19 antibodies, with no other associated factors.
Vagner Antonio Rodrigues daSilva, André Pinto Villarim, Monine Couto Farias Bem, Mauro Caldas Mendes Filho, Arthur Menino Castilho, Thiago Freire Pinto Bezerra, Joel Lavinsky   +6 more
doaj   +1 more source

Reliable and accurate diagnostics from highly multiplexed sequencing assays [PDF]

, 2020
Scalable, inexpensive, and secure testing for SARS-CoV-2 infection is crucial for control of the novel coronavirus pandemic. Recently developed highly multiplexed sequencing assays (HMSAs) that rely on high-throughput sequencing can, in principle, meet ...
Bloom, Joshua S., Booeshaghi, A. Sina, Cooper, Aaron R., Gehring, Jase, Kosuri, Sriram, Lubock, Nathan B., Luebbert, Laura, Pachter, Lior, Simpkins, Scott W.   +8 more
core  

COVID-19 publications: Database coverage, citations, readers, tweets, news, Facebook walls, Reddit posts [PDF]

, 2020
© 2020 The Authors. Published by MIT Press. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1162/qss_a_00066The COVID ...
Adie E., Chen Q., Clark F., Colavizza G., Costas R., de Solla Price D., Delwiche F. A., Fairclough R., Gunn W., Harzing A. W., Haustein S., Haustein S., Haustein S., Holmberg K., Ioannidis J. P., Kostoff R. N., Kousha K., Kousha K., Lewison G., Merchant R. M., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Orduña-Malea E., Ortega J. L., Ortega J. L., Ovadia S., Pouris A., Pouris A., Rethlefsen M. L., Robinson-García N., Robinson-García N., Song P., Stegehuis C., Stoddard G., Sud P., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Tian D., Torres-Salinas D., Van Noorden R., Wallace M. L., WHO, Yu H., Zahedi Z., Zahedi Z., Zahedi Z.   +54 more
core   +2 more sources